Stille

Stille P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Stille (STIL.ST) as of Oct 26, 2026 is 43.74. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 21.44 — a change of 103.95% (higher).

P/CF

43.74

YoY

103.95%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Stille is 2025 43.74 . P/CF (Price-to-Cash-Flow Ratio) of Stille was 2024 21.44 . It decreases by 103.95% higher compared to the previous year.

The Stille P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
117.23 SEK
Jan 1, 2019
61.10 SEK
Jan 1, 2020
76.71 SEK
Jan 1, 2021
216.67 SEK
Jan 1, 2022
49.38 SEK
Jan 1, 2023
42.30 SEK
Jan 1, 2024
21.44 SEK
Jan 1, 2025
43.74 SEK
The Stille P/CF history
YEARP/CFYoY
43.74+103.95%
21.44-49.31%
42.30-14.33%
49.38-77.21%
216.67+182.44%
76.71+25.56%
61.10-47.88%
117.23+40.84%
83.23+2.47%
81.23-44.63%
146.71-112.57%
-1,167.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

P/CF (Price-to-Cash-Flow Ratio) of Stille is 43.74 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Stille changed from 21.44 to 43.74, representing a 103.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Stille since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Stille

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Stille